QIN; Gangjian
Patent Applications and Registrations
Patent applications and USPTO patent grants for QIN; Gangjian.The latest application filed is for "compositions and methods for treatment of diabetes, obesity, hyper-cholesterolemia, and atherosclerosis by inhibition of sam68".
- QIN; Gangjian - Birmingham AL
- Qin; Gangjian - Chicago IL
- Qin; Gangjian - Boston MA
| Patent | Date |
|---|---|
| Compositions And Methods For Treatment Of Diabetes, Obesity, Hyper-cholesterolemia, And Atherosclerosis By Inhibition Of Sam68 App 20220119511 - QIN; Gangjian ; et al. | 2022-04-21 |
| Methods of using E2F2 for the treatment of hypertension Grant 9,187,540 - Losordo , et al. November 17, 2 | 2015-11-17 |
| Methods of Using E2F2 for the Treatment of Hypertension App 20100130414 - Losordo; Douglas W. ; et al. | 2010-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 